Investigational long-acting insulin (unnamed)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational long-acting insulin (unnamed), covering 2025-05-23 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting [Phase 1]